Hochschulschrift
Investigation of the preparation and formulation of pharmaceutical polymers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
125 Seiten
- Sprache
-
Deutsch
- Anmerkungen
-
Illustrationen, Diagramme
Friedrich-Schiller-Universität Jena, Dissertation, 2017
- Schlagwort
-
Wirkstofffreisetzung
Eudragit
Parenterales Arzneimittel
Polylactid-co-Glycolid
Biologisch abbaubarer Kunststoff
Wirkstofffreisetzung
Parenterales Arzneimittel
Eudragit
Arzneimittelentwicklung
Arzneimitteldesign
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2017]
Ähnliche Objekte (12)
Dry Foams in pharmaceutical formulation
Preparation of nanosized pharmaceutical formulations by dual centrifugation
Optimization of processes for biodegradable polymers manufacturing and formulation
Preparation of nanodispersions by antisolvent precipitation : a new formulation approach
Nanosuspensions - versatile formulation for pharmaceutical, cosmetic & food products
Innovative Pharmaceutical Stabilization and Formulation Techniques for Protein Drugs
Systematic evaluation of electronic taste sensing systems for pharmaceutical analysis and formulation development
Preparation and characterization of dual functional antimicrobial (bio)degradable polymers
Synthesis of boron-cluster containing amino acids and preparation of their polymers
The development of sustained release formulation for pharmaceutical proteins based on vesicular phospholipid gels
Rapid-acting and human insulins : hexamer dissociation kinetics upon dilution of the pharmaceutical formulation
Preparation and characterization of biodegradable hyperbranched polymers via A2 + B3 polycondensation
Dry Foams in pharmaceutical formulation
Preparation of nanosized pharmaceutical formulations by dual centrifugation
Optimization of processes for biodegradable polymers manufacturing and formulation
Preparation of nanodispersions by antisolvent precipitation : a new formulation approach
Nanosuspensions - versatile formulation for pharmaceutical, cosmetic & food products
Innovative Pharmaceutical Stabilization and Formulation Techniques for Protein Drugs
Systematic evaluation of electronic taste sensing systems for pharmaceutical analysis and formulation development
Preparation and characterization of dual functional antimicrobial (bio)degradable polymers
Synthesis of boron-cluster containing amino acids and preparation of their polymers
The development of sustained release formulation for pharmaceutical proteins based on vesicular phospholipid gels
Rapid-acting and human insulins : hexamer dissociation kinetics upon dilution of the pharmaceutical formulation
Preparation and characterization of biodegradable hyperbranched polymers via A2 + B3 polycondensation
Dry Foams in pharmaceutical formulation
Preparation of nanosized pharmaceutical formulations by dual centrifugation
Optimization of processes for biodegradable polymers manufacturing and formulation
Preparation of nanodispersions by antisolvent precipitation : a new formulation approach
Nanosuspensions - versatile formulation for pharmaceutical, cosmetic & food products
Innovative Pharmaceutical Stabilization and Formulation Techniques for Protein Drugs
Systematic evaluation of electronic taste sensing systems for pharmaceutical analysis and formulation development
Preparation and characterization of dual functional antimicrobial (bio)degradable polymers
Synthesis of boron-cluster containing amino acids and preparation of their polymers
The development of sustained release formulation for pharmaceutical proteins based on vesicular phospholipid gels
Rapid-acting and human insulins : hexamer dissociation kinetics upon dilution of the pharmaceutical formulation